boxed
color
#d9d9d9
https://canaim.ca/wp-content/themes/smartbox-installable/
https://canaim.ca/
#26ade4
style2
Developing novel methods to study drug safety and effectiveness
514.934.1934 ext.44844
McGill University Health Centre
ABSTRACT
Purpose Days supply (prescription duration) values are commonly used to estimate drug exposure and quantify adherence to therapy, yet
accuracy is not routinely assessed, and potential inaccurate reporting has been previously identified. We examined the impact of cleaning
days supply values on the measurement of adherence to oral bisphosphonates.
Methods We identified new users of oral bisphosphonates among Ontario seniors (April 2001–March 2011). Days supply values were
examined by dose, and we identified misclassification by comparing observed values to dose-specific expected values. Days supply values
not matching expected values were cleaned using dose-specific algorithms. One-year adherence to therapy was defined using measures
of compliance (mean proportion of days covered [PDC], and categorized into high [PDC ≥ 80%], medium [50% [PDC ≤ 50%]) and persistence (30-day permissible gap). Estimates were compared using the observed and cleaned days supply values,
stratified by site of patient residence (community or long-term care [LTC]).
Results We identified 337 729 (5% LTC) eligible new users. Among LTC patients, adherence estimates increased significantly following
data cleaning: mean PDC (59 to 83%), proportion with high compliance (47 to 76%), and proportion persisting with therapy (62 to 78%).
Modest increases were identified among community-dwelling patients following data cleaning (mean PDC, 71 to 74%; high compliance, 54
to 58%; and persistence, 56 to 61%).
Conclusions Data cleaning to correct for exposure misclassification can influence estimates of adherence with oral bisphosphonate therapy,
particularly in LTC. Results highlight the importance of developing data cleaning strategies to correct for exposure misclassification
and improve transparency in pharmacoepidemiologic studies.
Burden_et_al-2015-Pharmacoepidemiology_and_Drug_Safety.pdf
File Size457.1 KiB
DateNovember 5, 2015
Downloads634
AuthorAndrea M. Burden, J. Michael Paterson, Andrea Gruneir and Suzanne M. Cadarette
scroll
Loading posts...
magnifier
#6E787E
on
fadeInUp
loading
#6E787E
on
Back